TNF and COVID-19: Further, despite the fact that people with IBD were not included in clinical trials for COVID-19 vaccine safety and efficacy, there is now robust data to show that these vaccines are safe and elicit excellent immune responses in those with IBD; however, there is a blunted antibody response for those taking prednisone and those on anti-TNF therapies.